Effects of oral treatment with TNP-470 on rainbow trout (Oncorhynchus mykiss) infected with Tetracapsuloides bryosalmonae (Malacosporea), the causative agent of proliferative kidney disease

Aquaculture

Volumn 221, Issue 1-4, 2003, Pages 51-64

  Morris, D J ^a   Adams, A ^a   Smith, P ^b   Richards, R H ^a  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b Aquaculture Vaccines Limited   (United Kingdom)

Author keywords

Fumagillin; PKD; PKX; Tetracapsuloides bryosalmonae; TNP 470

Indexed keywords

DISEASE; DISEASE CONTROL; SALMONID CULTURE;

BACTERIA (MICROORGANISMS); MALACOSPOREA; MYKISS; ONCORHYNCHUS MYKISS; ONCORHYNCHUS NERKA; SALMONIDAE; TETRACAPSULOIDES BRYOSALMONAE;

EID: 0037402482     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0044-8486(03)00024-3     Document Type: Article

References (25)

1. Alderman, D.J., 1985. Malachite green: a review. J. Fish Dis. 8, 289-298.
2. Alderman, D.J., Clifton-Hadley, R.S., 1988. Malachite green therapy of proliferative kidney disease in rainbow trout: field trials. Vet. Rec. 122, 103-106.
3. Canning, E.U., Curry, A., Feist, S.W., Longshaw, M., Okamura, B., 1999. Tetracapsula bryosalmonae n. sp. for PKX organism, the cause of PKD in salmonid fish. Bull. Eur. Assoc. Fish Pathol. 19, 203-206.
4. Canning, E.U., Tops, S., Currie, A., Wood, T.S., Okamura, B., 2002. Ecology, development and pathogenicity of Buddenbrockia plumatellae Schroder 1910 (Myxozoa, Malacospora) (syn. Tetracapsula bryozoides) and establishment of Tetracapsuloides n. gen. for Tetracapsula bryosalmonae. J. Eukaryot. Microbiol. 49, 280-295.
5. Clifton-Hadley, R.S., Bucke, D., Richards, R.H., 1987. A study of the sequential clinical and pathological changes during proliferative kidney disease in rainbow trout, Salmo gairdneri Richardson. J. Fish Dis. 10, 335-352.
6. Ferguson, H.W., 1981. The effects of water temperature on the development of proliferative kidney disease in rainbow trout Salmo gairdneri Richardson. J. Fish Dis. 4, 175-177.
7. Ferguson, H.W., Ball, H.J., 1979. Epidemiological aspects of proliferative kidney disease amongst rainbow trout Salmo gairdneri Richardson in Northern Ireland. J. Fish Dis. 2, 219-225.
8. Ferguson, H.W., Needham, E.A., 1978. Proliferative kidney disease in rainbow trout Salmo gairdneri Richardson. J. Fish Dis. 1, 91-108.
9. Gerundo, N., Alderman, D.J., Clifton-Hadley, R.S., Feist, S.W., 1991. Pathological effects of repeated doses of malachite green: a preliminary study. J. Fish Dis. 14, 521-532.
10. Griffith, E.C., Su, Z., Niwayama, S., Ramsey, C.A., Chang, Y.-W., 1998. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc. Natl. Acad. Sci. U. S. A. 95, 15183-15188.
11. Hedrick, R.P., Groff, J.M., Foley, P., McDowell, T., 1988. Oral administration of fumagillin DCH protects Chinook salmon Onchorhynchus tshawytscha from experimentally induced proliferative kidney disease. Dis. Aquat. Org. 4, 165-168.
12. Hedrick, R.P., MacConnell, E., de Kinkelin, P., 1993. Proliferative kidney disease of salmonid fish. Ann. Rev. Fish Dis. 3, 277-290.
13. Higgins, M.J., Kent, M.L., 1998. TNP-470, the analogue of fumagillin DCH, controls PKX in naturally infected sockeye salmon, Oncorhynchus nerka (Walbaum), underyearlings. J. Fish Dis. 21, 455-457.
14. Higgins, M.J., Kent, M.L., Moran, D.J.W., Weiss, L.M., Dawe, S.C., 1998. Efficacy of the fumagillin analogue TNP-470 for Nucleospora salmonis and Loma salmonae infections in Chinook salmon Oncorhynchus tshawytscha. Dis. Aquat. Org. 34, 45-49.
15. Lauren, D.J., Wishkovsky, A., Groff, J.M., Hedrick, R.P., Hinton, D.E., 1989. Toxicity and pharmacokinetics of the antibiotic fumagillin in yearling rainbow trout (Salmo gairdneri). Toxicol. Appl. Pharmacol. 98, 444-453.
16. Le Gouvello, R., Pobel, T., Richards, R.H., Gould, C., 1999. Field efficacy of a 10-day treatment of fumagillin against proliferative kidney disease in rainbow trout Oncorhynchus mykiss. Aquaculture 171, 27-40.
17. Meyer, F.P., Jorgenson, T.A., 1988. Teratological and other effects of malachite green on development of rainbow trout and rabbits. Trans. Am. Fish. Soc. 112, 818-824.
18. Morris, D.J., Adams, A., 2002. PCR and in situ hybridisation of Tetracapsula bryosalmonae (PKX) the agent of proliferative kidney disease. In: Cunningham, C. (Ed.), Molecular Diagnosis of Salmonid Diseases. Kluwer Academic Publishing, Dordrecht, The Netherlands, pp. 299-313.
19. Morris, D.J., Adams, A., Richards, R.H., 2000. In situ hybridisation identifies the gill as a portal of entry for PKX (Phylum Myxozoa), the causative agent of proliferative kidney disease in salmonids. Parasitol. Res. 86, 950-956.
20. Ong, V.S., Stamm, G.E., Menacherry, S., Chu, S., 1998. Quantitation of TNP-470 and its metabolites in human plasma: sample handling, assay performance and stability. J. Chromatogr., B 710, 173-182.
21. Saulnier, D., de Kinkelin, P., 1996. Antigenic and biochemical study of PKX, the myxosporean causative agent of proliferative kidney disease of salmonid fish. Dis. Aquat. Org. 27, 103-114.
22. Seagrave, C.P., Bucke, D., Hudson, E.B., McGregor, D., 1981. A survey of the prevalence and distribution of proliferative kidney disease (PKD) in England and Wales. J. Fish Dis. 4, 437-439.
23. Turk, B.E., Su, Z., Lui, J.O., 1998. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression. Biol. Med. Chem. 6, 1163-1169.
24. Veterinary Medicines Directorate (VMD), 1996. 1995 - Non-statutory Survellance Results (Final). Medicines Act Veterinary Information Service (MAVIS), April, 19-20.
25. Wishkovsky, A., Groff, J.M., Lauren, D.J., Toth, R.J., Hedrick, R.P., 1990. Efficacy of fumagillin against proliferative kidney disease and its toxic side effects in rainbow trout (Oncorhynchus mykiss) fingerlings. Fish Pathol. 25, 141-146.